1. Home
  2. PTIX vs GV Comparison

PTIX vs GV Comparison

Compare PTIX & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • GV
  • Stock Information
  • Founded
  • PTIX 1994
  • GV 2013
  • Country
  • PTIX United States
  • GV Canada
  • Employees
  • PTIX N/A
  • GV N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • PTIX Health Care
  • GV Real Estate
  • Exchange
  • PTIX Nasdaq
  • GV Nasdaq
  • Market Cap
  • PTIX 6.3M
  • GV 6.8M
  • IPO Year
  • PTIX 2016
  • GV 2022
  • Fundamental
  • Price
  • PTIX $2.76
  • GV $1.58
  • Analyst Decision
  • PTIX
  • GV
  • Analyst Count
  • PTIX 0
  • GV 0
  • Target Price
  • PTIX N/A
  • GV N/A
  • AVG Volume (30 Days)
  • PTIX 73.5K
  • GV 732.6K
  • Earning Date
  • PTIX 11-13-2025
  • GV 11-11-2025
  • Dividend Yield
  • PTIX N/A
  • GV N/A
  • EPS Growth
  • PTIX N/A
  • GV N/A
  • EPS
  • PTIX N/A
  • GV N/A
  • Revenue
  • PTIX N/A
  • GV $7,773,905.00
  • Revenue This Year
  • PTIX N/A
  • GV N/A
  • Revenue Next Year
  • PTIX N/A
  • GV N/A
  • P/E Ratio
  • PTIX N/A
  • GV N/A
  • Revenue Growth
  • PTIX N/A
  • GV N/A
  • 52 Week Low
  • PTIX $2.25
  • GV $1.00
  • 52 Week High
  • PTIX $15.26
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 35.75
  • GV 42.51
  • Support Level
  • PTIX $2.85
  • GV $1.58
  • Resistance Level
  • PTIX $3.19
  • GV $1.70
  • Average True Range (ATR)
  • PTIX 0.23
  • GV 0.17
  • MACD
  • PTIX -0.04
  • GV -0.01
  • Stochastic Oscillator
  • PTIX 5.61
  • GV 26.42

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: